US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist

20.970
+1.140+5.75%

Close Nov 27 16:00 ET

20.970
0.0000.00%

Post 16:00 ET

700.76MMarket Cap-12686P/E (TTM)

MBX Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-89.80%-14.66M

-38.30%-31.98M

-11.15M

-7.73M

-23.12M

Net income from continuing operations

-78.51%-18.14M

-24.60%-32.56M

---8.84M

---10.16M

---26.14M

Operating gains losses

----

-92.90%69K

----

--972K

Depreciation and amortization

87.50%75K

180.36%157K

--41K

--40K

--56K

Other non cash items

12.50%27K

-77.16%95K

--25K

--24K

--416K

Change In working capital

54.63%2.77M

-156.98%-735K

---2.86M

--1.79M

--1.29M

-Change in prepaid assets

-562.60%-569K

-32.36%-1.05M

---1.32M

--123K

---791K

-Change in payables and accrued expense

98.24%3.38M

-78.47%457K

---1.49M

--1.7M

--2.12M

-Change in other current assets

----

80.95%-8K

----

---42K

-Change in other current liabilities

-8.57%-38K

---137K

---35K

--0

Cash from discontinued investing activities

Operating cash flow

-89.80%-14.66M

-38.30%-31.98M

---11.15M

---7.73M

---23.12M

Investing cash flow

Cash flow from continuing investing activities

-441.73%-100.79M

-171.03%-30.93M

-28.96M

-18.61M

-11.41M

Net PPE purchase and sale

-159.09%-57K

70.75%-129K

---55K

---22K

---441K

Net investment purchase and sale

-442.06%-100.73M

-180.75%-30.8M

---28.9M

---18.58M

---10.97M

Cash from discontinued investing activities

Investing cash flow

-441.73%-100.79M

-171.03%-30.93M

---28.96M

---18.61M

---11.41M

Financing cash flow

Cash flow from continuing financing activities

244.27%235.81M

50.27%69.22M

19K

68.5M

46.06M

Net issuance payments of debt

----

--0

----

--10M

Net preferred stock issuance

----

87.74%68.51M

--0

----

--36.49M

Proceeds from stock option exercised by employees

-282.35%-31K

2,363.33%739K

--19K

--17K

--30K

Net other financing activities

---2.2M

93.45%-30K

--0

----

---458K

Cash from discontinued financing activities

Financing cash flow

244.27%235.81M

50.27%69.22M

--19K

--68.5M

--46.06M

Net cash flow

Beginning cash position

-56.04%12.5M

90.93%24.21M

--70.61M

--28.44M

--12.68M

Current changes in cash

185.45%120.36M

-45.25%6.31M

---40.08M

--42.17M

--11.53M

End cash Position

88.18%132.87M

26.08%30.52M

--30.52M

--70.61M

--24.21M

Free cash flow

-90.00%-14.72M

-36.26%-32.11M

---11.2M

---7.75M

---23.56M

Currency Unit

USD

	(Q3)Sep 30, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-89.80%-14.66M	-38.30%-31.98M	-11.15M	-7.73M	-23.12M
Net income from continuing operations	-78.51%-18.14M	-24.60%-32.56M	---8.84M	---10.16M	---26.14M
Operating gains losses	----	-92.90%69K	----	----	--972K
Depreciation and amortization	87.50%75K	180.36%157K	--41K	--40K	--56K
Other non cash items	12.50%27K	-77.16%95K	--25K	--24K	--416K
Change In working capital	54.63%2.77M	-156.98%-735K	---2.86M	--1.79M	--1.29M
-Change in prepaid assets	-562.60%-569K	-32.36%-1.05M	---1.32M	--123K	---791K
-Change in payables and accrued expense	98.24%3.38M	-78.47%457K	---1.49M	--1.7M	--2.12M
-Change in other current assets	----	80.95%-8K	----	----	---42K
-Change in other current liabilities	-8.57%-38K	---137K	---35K	---35K	--0
Cash from discontinued investing activities
Operating cash flow	-89.80%-14.66M	-38.30%-31.98M	---11.15M	---7.73M	---23.12M
Investing cash flow
Cash flow from continuing investing activities	-441.73%-100.79M	-171.03%-30.93M	-28.96M	-18.61M	-11.41M
Net PPE purchase and sale	-159.09%-57K	70.75%-129K	---55K	---22K	---441K
Net investment purchase and sale	-442.06%-100.73M	-180.75%-30.8M	---28.9M	---18.58M	---10.97M
Cash from discontinued investing activities
Investing cash flow	-441.73%-100.79M	-171.03%-30.93M	---28.96M	---18.61M	---11.41M
Financing cash flow
Cash flow from continuing financing activities	244.27%235.81M	50.27%69.22M	19K	68.5M	46.06M
Net issuance payments of debt	----	--0	----	----	--10M
Net preferred stock issuance	----	87.74%68.51M	--0	----	--36.49M
Proceeds from stock option exercised by employees	-282.35%-31K	2,363.33%739K	--19K	--17K	--30K
Net other financing activities	---2.2M	93.45%-30K	--0	----	---458K
Cash from discontinued financing activities
Financing cash flow	244.27%235.81M	50.27%69.22M	--19K	--68.5M	--46.06M
Net cash flow
Beginning cash position	-56.04%12.5M	90.93%24.21M	--70.61M	--28.44M	--12.68M
Current changes in cash	185.45%120.36M	-45.25%6.31M	---40.08M	--42.17M	--11.53M
End cash Position	88.18%132.87M	26.08%30.52M	--30.52M	--70.61M	--24.21M
Free cash flow	-90.00%-14.72M	-36.26%-32.11M	---11.2M	---7.75M	---23.56M
Currency Unit	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Recent IPOs

Intraday-1.11%